跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Binozyt Powder for Oral Suspension 200mg/5ml - HSA Drug Approval Details
Approvals
/
HSA
/
Binozyt Powder for Oral Suspension 200mg/5ml
Approved
THERAPEUTIC
Binozyt Powder for Oral Suspension 200mg/5ml
Sandoz S.R.L.
🇸🇬 Health Sciences Authority
Approval Date
Dec 1, 2009
Approval ID
5fb9eb34e5cd8be5
Company
Sandoz S.R.L.
Type
Therapeutic
Approval Details
Approval Id
5fb9eb34e5cd8be5
Drug Name
Binozyt Powder for Oral Suspension 200mg/5ml
Product Name
Binozyt Powder for Oral Suspension 200mg/5ml
Approval Number
SIN13742P
Approval Date
2009-12-01
Registrant
NOVARTIS (SINGAPORE) PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
POWDER, FOR SUSPENSION
Route Of Administration
ORAL
Atc Code
J01FA10
Atc Item Name
azithromycin
Pharma Manufacturer Name
NOVARTIS (SINGAPORE) PTE LTD
Company Detail Path
/organization/novartis-singapore-pte-ltd
Active Ingredients
Azithromycin Monohydrate 204.8mg eqv Azithromycin
200mg/5ml
Azithromycin Monohydrate 204.8mg eqv Azithromycin
200mg/5ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Dec 1, 2009
Approval ID
5fb9eb34e5cd8be5
Type
Therapeutic
Back to HSA Approvals
